Page last updated: 2024-08-26

alpha-glutamyltryptophan and Malignant Melanoma

alpha-glutamyltryptophan has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, J; Fukumoto, J; Gill, PS; Masood, R; Sharma, S; Smith, DL; Wei, W; Zhu, S1

Other Studies

1 other study(ies) available for alpha-glutamyltryptophan and Malignant Melanoma

ArticleYear
Natural killer cell cytolytic activity is necessary for in vivo antitumor activity of the dipeptide L-glutamyl-L-tryptophan.
    International journal of cancer, 2003, Sep-10, Volume: 106, Issue:4

    Topics: Angiogenesis Inhibitors; Animals; Cell Division; Cytoplasmic Granules; Cytotoxicity, Immunologic; Dipeptides; Flow Cytometry; Humans; Interferon-gamma; Interleukin-12; Killer Cells, Natural; Lung Neoplasms; Melanoma; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplasms, Experimental; Perforin; Pore Forming Cytotoxic Proteins; T-Lymphocytes; Tumor Cells, Cultured

2003